Chapter 8. Modulators of peroxisome proliferator-activated receptors (PPARs)

作者: Daniel D. Sternbach

DOI: 10.1016/S0065-7743(03)38009-1

关键词:

摘要: Publisher Summary This chapter presents an overview of the modulators peroxisome proliferator-activated receptors (PPARs). PPARs comprise a family ligand-activated transcription factors belonging to nuclear receptor gene superfamily. There are three PPAR subtypes that products separate genes and commonly designated as PPARα, PPARγ, PPARδ. In addition ligand-binding domain (LBD), these also have N-terminal DNA binding domain. The is least well characterized bears little homology among subtypes. has somewhat greater remaining variation allows be pharmacologically distinct. Upon ligand, forms heterodimer with 9- cis -retinoic acid (RXR). highly conserved DNA-binding domains recognize, together their RXR partner, sequences (response elements) containing direct repeats hexanucleotide AGGTCA separated by one nucleotide. interacts downstream machinery ultimately turns on target genes. discusses X-ray crystal structures PPARδ fatty or synthetic fibrate ligand provides PPARα agonists, PPARγ modulators.

参考文章(63)
Per Sauerberg, Ingrid Pettersson, Lone Jeppesen, Paul S. Bury, John P. Mogensen, Karsten Wassermann, Christian L. Brand, Jeppe Sturis, Helle F. Wöldike, Jan Fleckner, Anne-Sofie T. Andersen, Steen B. Mortensen, L. Anders Svensson, Hanne B. Rasmussen, Søren V. Lehmann, Zdenek Polivka, Karel Sindelar, Vladimira Panajotova, Lars Ynddal, Erik M. Wulff, Novel Tricyclic-α-alkyloxyphenylpropionic Acids: Dual PPARα/γ Agonists with Hypolipidemic and Antidiabetic Activity Journal of Medicinal Chemistry. ,vol. 45, pp. 789- 804 ,(2002) , 10.1021/JM010964G
David M. Heery, Eric Kalkhoven, Susan Hoare, Malcolm G. Parker, A signature motif in transcriptional co-activators mediates binding to nuclear receptors Nature. ,vol. 387, pp. 733- 736 ,(1997) , 10.1038/42750
Ez-Zoubir Amri, Frédéric Bonino, Gérard Ailhaud, Nada A. Abumrad, Paul A. Grimaldi, Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. Journal of Biological Chemistry. ,vol. 270, pp. 2367- 2371 ,(1995) , 10.1074/JBC.270.5.2367
Bart Staels, Wolfgang Koenig, Aïda Habib, Régine Merval, Marilyne Lebret, Inés Pineda Torra, Philippe Delerive, Abdessamad Fadel, Giulia Chinetti, Jean-Charles Fruchart, Jamila Najib, Jacques Maclouf, Alain Tedgui, Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators Nature. ,vol. 393, pp. 790- 793 ,(1998) , 10.1038/31701
Z. Levi, A. Shaish, N. Yacov, H. Levkovitz, S. Trestman, Y. Gerber, H. Cohen, A. Dvir, R. Rhachmani, M. Ravid, D. Harats, Rosiglitazone (PPARγ‐agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes–atherosclerosis mouse model Diabetes, Obesity and Metabolism. ,vol. 5, pp. 45- 50 ,(2003) , 10.1046/J.1463-1326.2003.00240.X
Stefan Westin, Riki Kurokawa, Robert T. Nolte, G. Bruce Wisely, Eileen M. McInerney, David W. Rose, Michael V. Milburn, Michael G. Rosenfeld, Christopher K. Glass, Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators Nature. ,vol. 395, pp. 199- 202 ,(1998) , 10.1038/26040
Timothy M. Willson, Peter J. Brown, Daniel D. Sternbach, Brad R. Henke, The PPARs: from orphan receptors to drug discovery. Journal of Medicinal Chemistry. ,vol. 43, pp. 527- 550 ,(2000) , 10.1021/JM990554G
Christine Dreyer, Grigorios Krey, Hansjörg Keller, Francoise Givel, Gerd Helftenbein, Walter Wahli, Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors Cell. ,vol. 68, pp. 879- 887 ,(1992) , 10.1016/0092-8674(92)90031-7
Dawn A. Brooks, Garret J. Etgen, Christopher J. Rito, Anthony J. Shuker, Samuel J. Dominianni, Alan M. Warshawsky, Robert Ardecky, James R. Paterniti, John Tyhonas, Donald S. Karanewsky, Raymond F. Kauffman, Carol L. Broderick, Brian A. Oldham, Chahzrad Montrose-Rafizadeh, Leonard L. Winneroski, Margaret M. Faul, James R. McCarthy, Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists. Journal of Medicinal Chemistry. ,vol. 44, pp. 2061- 2064 ,(2001) , 10.1021/JM0155188